%0 Journal Article
%T Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer
%A Ali Hajjar
%A Mehmet A. Ergun
%A Murtuza Rampurwala
%A Oguzhan Alagoz
%J Archive of "PLoS ONE".
%D 2019
%R 10.1371/journal.pone.0217778
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550431/